Valeant Rejected Takeda Bid
May 27, 2016.
Reuters reports that Valeant Pharmaceuticals rejected a joint takeover offer from Japan's Takeda and TPG Capital Management this spring.
The offer was reportedly made a few weeks before Joseph Papa took over as Valeant's new chief executive in April.
More on the story here.
Recent Videos
Related Content
Is Artificial Intelligence a ‘Product’? Products Liability Implications for AI-Based Products
April 10th 2025Article
As the physical products we use evolve to become increasingly complex, traditional products liability frameworks may not always fit to provide remedies for harm that can result from using novel product types.
